AAVantgarde Advances Dual-AAV Gene Therapies for Usher Syndrome and Stargardt Disease

Inherited retinal diseases such as Usher syndrome and Stargardt disease remain difficult to treat, particularly when the genes involved are too large for c...

November 17, 2026 | Tuesday | Interaction
Quotient Sciences Advances AI-Guided Drug Formulation to Shorten Clinical Development

Developing effective drug formulations remains a major challenge for biopharma companies, particularly for molecules with poor solubility or complex releas...

November 16, 2026 | Monday | Interaction
MRM Health and Biocodex Advance €15 Million Manufacturing Partnership for Microbiome-Based Medicines

Bringing microbiome-based therapies to patients requires more than promising clinical results. Manufacturing complex mixtures of live bacteria consistently...

November 13, 2026 | Friday | Interaction
Pharvaris Reports Positive Phase 3 Results for Oral Deucrictibant in Hereditary Angioedema

For people living with hereditary angioedema (HAE), sudden and unpredictable swelling attacks can disrupt daily life and require urgent treatment. Pharva...

November 12, 2026 | Thursday | News
InnoCare Advances Dual-Target Antibody ICP-B161 for Inflammatory Bowel Disease Treatment

For patients living with inflammatory bowel disease (IBD), persistent symptoms, repeated treatment failures and the need for lifelong therapy remain major ...

November 11, 2026 | Wednesday | Interaction
SOTERIA’s CANCER HUNT Programme Expands Free Precision Cancer Care for US Veterans and Military Personnel

For military personnel and veterans diagnosed with cancer, accessing specialised testing and treatment options can be difficult, particularly when care...

November 09, 2026 | Monday | Interview
Gesynta Pharma Advances Non-Hormonal Endometriosis Treatment Vipoglanstat Following Early Phase 2 Trial Enrolment

For millions of women living with endometriosis, persistent pain can disrupt daily life, affect fertility and limit treatment choices. Existing hormonal th...

November 05, 2026 | Thursday | Interaction
Ambrose Healthcare’s Rare Disease Strategy: Reviving Promising Therapies Through Strategic Acquisitions

Ambrose Healthcare’s acquisition of AM-Pharma, valued at up to €161 million plus royalties, strengthens its rare disease pipeline and establishe...

November 04, 2026 | Wednesday | Interview
Axplora Advances Axotecan Development to Strengthen European Exatecan Supply for ADC Manufacturers

As demand for Exatecan-based antibody-drug conjugates (ADCs) grows, securing reliable manufacturing capacity and diversified supply chains has become a pri...

October 30, 2026 | Friday | Interaction
Grünenthal on Expanding Pain Treatment Access Across Asia-Pacific

Biopharma Boardroom speaks with Quentin Le Masne de Chermont, Head of Corporate Strategy and Business Development at Grünenthal Group, a...

October 13, 2026 | Tuesday | Interview
QIAGEN Expands QIAstat-Dx Bloodstream Infection Testing in the US

Biopharma Boardroom speaks with Nadia Aelbrecht, Vice President, Head of Infectious Disease at QIAGEN, about rapid diagnostics, antimicrobial...

October 12, 2026 | Monday | Interview
Elevar Therapeutics Receives FDA Approval for Lyrfigtu in FGFR2-Altered Bile Duct Cancer

Elevar Therapeutics, Inc., a majority-owned subsidiary of HLB Co., Ltd. and a fully integrated biopharmaceutical company dedicated to elevating treatment...

September 25, 2026 | Friday | News
Symbiosis Expands Sterile Manufacturing Capacity with £26m Investment

        Symbiosis Pharmaceutical Services is entering a new phase of growth following a £26 million investment to expand its ...

September 23, 2026 | Wednesday | Interview
Seeing Biologics in Action: The Next Frontier in Analytical Science

  As biologics and novel modalities become increasingly sophisticated, understanding molecular structure under controlled conditions tells only part ...

September 17, 2026 | Thursday | Interaction

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close